Cargando…

The low-density lipoprotein receptor–mTORC1 axis coordinates CD8(+) T cell activation

Activation of T cells relies on the availability of intracellular cholesterol for an effective response after stimulation. We investigated the contribution of cholesterol derived from extracellular uptake by the low-density lipoprotein (LDL) receptor in the immunometabolic response of T cells. By co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonacina, Fabrizia, Moregola, Annalisa, Svecla, Monika, Coe, David, Uboldi, Patrizia, Fraire, Sara, Beretta, Simona, Beretta, Giangiacomo, Pellegatta, Fabio, Catapano, Alberico Luigi, Marelli-Berg, Federica M., Norata, Giuseppe Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499829/
https://www.ncbi.nlm.nih.gov/pubmed/36129440
http://dx.doi.org/10.1083/jcb.202202011
Descripción
Sumario:Activation of T cells relies on the availability of intracellular cholesterol for an effective response after stimulation. We investigated the contribution of cholesterol derived from extracellular uptake by the low-density lipoprotein (LDL) receptor in the immunometabolic response of T cells. By combining proteomics, gene expression profiling, and immunophenotyping, we described a unique role for cholesterol provided by the LDLR pathway in CD8(+) T cell activation. mRNA and protein expression of LDLR was significantly increased in activated CD8(+) compared to CD4(+) WT T cells, and this resulted in a significant reduction of proliferation and cytokine production (IFNγ, Granzyme B, and Perforin) of CD8(+) but not CD4(+) T cells from Ldlr −/− mice after in vitro and in vivo stimulation. This effect was the consequence of altered cholesterol routing to the lysosome resulting in a lower mTORC1 activation. Similarly, CD8(+) T cells from humans affected by familial hypercholesterolemia (FH) carrying a mutation on the LDLR gene showed reduced activation after an immune challenge.